Results 121 to 130 of about 45,532 (172)

Machine learning prediction of functional cure to pegylated interferon-alpha therapy in two HBV populations: Advantaged populations and HBeAg-negative patients. [PDF]

Virulence
Li J, Li H, Lin C, Jiang R, Wang L, He Y, Yang X, Gong K, Xun Z, Zheng Q.   +9 more
europepmc   +1 more source

Enhancing off-nucleos(t)ide analogue outcome predictions in chronic hepatitis B with time-varying hepatitis B core-related antigen [PDF]

Clinical and Molecular Hepatology
Chen-Te Huang, Tai-Chung Tseng
doaj   +1 more source

Spatial transcriptional profiling of CHB liver biopsies reveals an undetected population of zonally biased HBV-integrated cells. [PDF]

JHEP Rep
Mahadevan S, Ramirez R, Mehrabian H, Moon C, Mohan A, Vaquero E, Win R, Chaudhuri S, Chuang HC, Sun KH, Aggarwal A, Rao A, Li L, Fletcher SP, Balsitis S, Diehl L, Holdorf MM.   +16 more
europepmc   +1 more source

Unveiling the Hidden Reservoir: High Prevalence of Occult Hepatitis B and Associated Surface Gene Mutations in a Healthy Vietnamese Adult Cohort. [PDF]

Microorganisms
Thu HHK, Ostankova YV, Shchemelev AN, Serikova EN, Davydenko VS, Ton T, Lien TTX, Ramsay ES, Totolian AA.   +8 more
europepmc   +1 more source

Implications of occult hepatitis B infection for blood donor management: a five-year evaluation from Western Saudi Arabia. [PDF]

BMC Infect Dis
Tounsi WA, Noorsaeed S, Almars AI, Almramhi MM, Basri AM, Basabrain AA, Rokan A, Almansouri TS, Mokhtar SH, Hakami NY.   +9 more
europepmc   +1 more source

Molecular Characterization of Atypical Hepatitis B Serological Profiles in HBsAg-Negative Women of Childbearing Age in Gabon. [PDF]

Curr Issues Mol Biol
Mikelet Boussoukou IP, Andeme Eyi AS, Ondh-Obame JA, Ondamba PJN, Magossou Mbadinga MJ, Makoyo Komba O, Omouessi ST, Djoba Siawaya JF, Ndeboko B.   +8 more
europepmc   +1 more source

Comparative effectiveness of tenofovir versus entecavir combined with peginterferon Alfa-2b for functional cure in HBeAg-negative chronic hepatitis B: a propensity score-matched analysis. [PDF]

BMC Infect Dis
Wang PP, Wu HS, Deng WJ, Wu Y, Zhang Y, Gao ZL, Mo ZS.   +6 more
europepmc   +1 more source

Association between fatty liver and risk of liver failure in patients with acute hepatitis B: a retrospective cohort study. [PDF]

Front Cell Infect Microbiol
Wang XH, Chang YN, Zhang L, Yang YL, Liang LW, Zeng Y, Zhou Z, Zhong S, Li H.   +8 more
europepmc   +1 more source

Auranofin, identified by FDA-approved drug library screening, inhibits HBs antigen secretion via lysosomal damage. [PDF]

PLoS One
Shimoda A, Murai K, Hikita H, Minami S, Miyake T, Kuriki S, Sometani E, Sung J, Shigeno S, Higuchi Y, Maesaka K, Shirai K, Tahata Y, Saito Y, Kodama T, Takahashi T, Suemizu H, Takehara T.   +17 more
europepmc   +1 more source

Hepatitis B virus testing, vaccination, and hepatitis B surface antigen prevalence among adult inpatients at an urban polyclinic in Accra, Ghana: a cross-sectional study. [PDF]

Infect Prev Pract
Jingbeja E, Alhassan Y, Peazang Ibrahim GJ, Boachie J, Addo-Lartey A.   +4 more
europepmc   +1 more source